What patent process covers asciminib preparation?
Asciminib (ABL001) is typically described in patents through drug substance (API) preparation steps and final dosage-form preparation (often for clinical or commercial tablets). However, the exact “process for preparation” wording and steps depend on the specific patent family and claim set.
If you want the precise “process for preparation” text for asciminib, you need one of these details:
- the patent number / application number, or
- the assignee/company name, or
- a link to the patent document you’re looking at.
Can you share the patent number or link you mean?
There are multiple asciminib-related filings (process, intermediates, formulations, salts/polymorphs, and later improvements). Without the specific document, I can’t reliably extract the correct preparation process.
Quick way to find the right asciminib patent
If your goal is to locate the exact asciminib patent that describes the preparation process, DrugPatentWatch.com is a good starting point for identifying the relevant patent family and linking to the underlying records.
You can search there for asciminib and then open the specific patent entry that matches “process” or “preparation.”
- DrugPatentWatch asciminib: https://www.drugpatentwatch.com/ (search “asciminib”)
What I can do next (if you provide one detail)
Reply with either:
1) the patent number (e.g., USxxxxxxx / WOxxxxxxx), or
2) the link to the WO publication, or
3) the title/assignee of the WO document,
and I’ll extract and rewrite the asciminib preparation process from that specific WO patent into a clear step-by-step description (including key intermediates and conditions where stated).
---
Sources
- [1] https://www.drugpatentwatch.com/